Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary


Ligand Pharmaceuticals is owned by 91.49% institutional investors, 1.98% insiders, and 6.52% retail investors. Blackrock is the largest institutional shareholder, holding 16.19% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.07% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals91.49%1.98%6.52%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.87M16.19%$241.95M
Blackrock funding, inc. /de2.95M15.99%$315.67M
Vanguard group2.09M11.32%$223.47M
Janus henderson group1.02M5.51%$108.76M
Macquarie group884.38K4.80%$94.76M
Dimensional fund advisors lp723.02K3.93%$77.47M
State street688.77K3.88%$58.04M
Congress asset management co /ma621.48K3.37%$66.59M
Stephens investment management group612.78K3.33%$65.66M
Chicago capital551.59K2.99%$59.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ashford capital management322.21K3.67%$27.15M
Cardinal capital management llc /ct133.67K3.08%$11.26M
Villere st denis j287.04K2.78%$30.76M
Acuitas investments27.51K2.42%$2.95M
Rice hall james & associates304.93K1.79%$32.67M
Chicago capital551.59K1.57%$59.10M
Private capital management133.69K1.50%$14.32M
Essex investment management65.25K1.26%$6.99M
Penn capital management company104.43K1.10%$11.19M
Lisanti capital growth39.01K1.01%$4.18M

Top Buyers

HolderShares% AssetsChange
Massachusetts financial services co /ma/276.73K0.01%276.73K
Ashford capital management322.21K3.67%125.67K
Vanguard group2.09M0.00%115.00K
Franklin resources185.40K0.01%90.74K
Norges bank46.29K0.00%46.29K

Top Sellers

HolderShares% AssetsChange
Cardinal capital management llc /ct133.67K3.08%-425.56K
William blair investment management---205.69K
Villere st denis j287.04K2.78%-187.81K
Knott david m jr---85.00K
F/m investments52.88K0.21%-81.42K

New Positions

HolderShares% AssetsChangeValue
Massachusetts financial services co /ma/276.73K0.01%276.73K$29.65M
Norges bank46.29K0.00%46.29K$4.96M
Raymond james financial21.83K0.00%21.83K$2.34M
State of new jersey common pension fund d18.78K0.01%18.78K$2.01M
Squarepoint ops16.80K0.00%16.80K$1.80M

Sold Out

HolderChange
Mendota financial group-1.00
Cgc financial services-3.00
Tidemark-4.00
Voisard asset management group-5.00
Avion wealth-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024239-2.85%16,852,409-6.71%910.95%135-577.55%
Sep 30, 20242454.26%18,062,9964.71%981.04%1359.76%53-26.39%
Jun 30, 20242322.65%17,221,3794.99%971.08%12223.23%70-
Mar 31, 20242264.63%16,402,7201.60%941.10%99-6.60%70-4.11%
Dec 31, 20232169.09%16,144,8493.07%921.13%10626.19%73-6.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.17M6.07%736.00
Delaware Small Cap Core I655.86K3.59%-57.44K
Macquarie Small Cap Core I655.86K3.41%-
Janus Henderson US SMID Cap Growth613.48K3.25%-12.60K
Janus Henderson US SMID Cap Growth MA613.48K3.25%613.44K
Janus Henderson Triton D610.15K3.17%-3.33K
Vanguard Total Stock Mkt Idx Inv577.20K3.00%513.00
Vanguard US Total Market Shares ETF529.85K2.75%-
iShares Russell 2000 ETF473.81K2.46%-4.13K
Vanguard Small Cap Index458.31K2.38%378.00

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2025Espinoza Octavio Chief Financial OfficerSell$575.15K
Dec 23, 2024Espinoza Octavio Chief Financial OfficerSell$244.85K
Nov 27, 2024LAMATTINA JOHN L-Sell$297.50K
Sep 23, 2024Reardon Andrew CLO & SecretarySell$199.20K
Sep 20, 2024Espinoza Octavio Chief Financial OfficerSell$20.80K

Insider Transactions Trends


DateBuySell
2025 Q1-1
2024 Q4-2
2024 Q3115
2024 Q2-9
2024 Q1-2

LGND Ownership FAQ


Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 91.49%, followed by 1.98% insiders and 6.53% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Ligand Pharmaceuticals exceeds.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Blackrock (2.87M shares, 16.19%), Blackrock funding, inc. /de (2.95M shares, 15.99%), and Vanguard group (2.09M shares, 11.32%). Together, they hold 43.51% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ashford capital management is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.67% of its assets in 322.21K Ligand Pharmaceuticals shares, valued at 27.15M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 6.07% of its total shares outstanding invested in 1.17M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools